Friess Associates LLC Axogen, Inc. Transaction History
Friess Associates LLC
- $59.9 Million
- Q2 2022
A detailed history of Friess Associates LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Friess Associates LLC holds 253,546 shares of AXGN stock, worth $3.97 Million. This represents 3.47% of its overall portfolio holdings.
Number of Shares
253,546
Previous 421,651
39.87%
Holding current value
$3.97 Million
Previous $3.35 Million
37.96%
% of portfolio
3.47%
Previous 1.79%
Shares
13 transactions
Others Institutions Holding AXGN
# of Institutions
162Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$64 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$50.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$47 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$45.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$37.9 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $661M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...